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This fact sheet summarizes information in four 
areas of male circumcision: 1) male circumcision 
and risk for HIV transmission; 2) male 
circumcision and other health conditions; 3) risks 
associated with male circumcision; and 4) status of 
HIV infection and male circumcision in the United 
States.
What is Male Circumcision?
Male circumcision is the surgical removal of some 
or all of the foreskin (or prepuce) from the penis 
[1]. 
Male Circumcision and Risk for 
HIV Transmission
Several types of research have documented that 
male circumcision significantly reduces the risk of 
HIV acquisition by men during penile-vaginal sex.
Biologic Plausibility
Compared with the dry external skin surface, the 
inner mucosa of the foreskin has less keratinization 
(deposition of fibrous protein), a higher density of 
target cells for HIV infection (Langerhans cells), 
and is more susceptible to HIV infection than other 
penile tissue in laboratory studies [2]. The foreskin 
may also have greater susceptibility to traumatic 
epithelial disruptions (tears) during intercourse, 
providing a portal of entry for pathogens, including 
HIV [3]. In addition, the microenvironment in the 
preputial sac between the unretracted foreskin and 
the glans penis may be conducive to viral survival 
[1]. Finally, the higher rates of sexually transmitted 
genital ulcerative disease, such as syphilis, 
observed in uncircumcised men may also increase 
susceptibility to HIV infection [4].
International Observational Studies
A systematic review and meta-analysis that 
focused on male circumcision and heterosexual 
transmission of HIV in Africa was published in 
2000 [5]. It included 19 cross-sectional studies, 5 
case-control studies, 3 cohort studies, and 1 partner 
study. A substantial protective effect of male 
circumcision on risk for HIV infection was noted, 
along with a reduced risk for genital ulcer disease. 
After adjustment for confounding factors in the 
population-based studies, the relative risk for HIV 
infection was 44% lower in circumcised men. The 
strongest association was seen in men at high risk, 
such as patients at sexually transmitted disease 
(STD) clinics, for whom the adjusted relative risk 
was 71% lower for circumcised men. 
Another review that included stringent assessment 
of 10 potential confounding factors and was 
stratified by study type or study population was 
published in 2003 [6]. Most of the studies were 
from Africa. Of the 35 observational studies in 
the review, the 16 in the general population had 
inconsistent results. The one large prospective 
cohort study in this group showed a significant 
protective effect: the odds of infection were 42% 
lower for circumcised men [7]. The remaining 
19 studies were conducted in populations at high 
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risk. These studies found a consistent, substantial 
protective effect, which increased with adjustment 
for confounding. Four of these were cohort 
studies: all demonstrated a protective effect, with 
two being statistically significant. 
Ecologic studies also indicate a strong association 
between lack of male circumcision and HIV 
infection at the population level. Although links 
between circumcision, culture, religion, and risk 
behavior may account for some of the differences 
in HIV infection prevalence, the countries 
in Africa and Asia with prevalence of male 
circumcision of less than 20% have HIV infection 
prevalences several times higher than those in 
countries in these regions where more than 80% of 
men are circumcised [8].
International Clinical Trials
Three randomized controlled clinical trials 
were conducted in Africa to determine whether 
circumcision of adult males will reduce their 
risk for HIV infection. The study conducted in 
South Africa [9] was stopped in 2005, and those 
in Kenya [10] and Uganda [11] were stopped in 
2006 after interim analyses found a statistically 
significant reduction in male participants’ risk for 
HIV infection from medical circumcision. 
In these studies, men who had been randomly 
assigned to the circumcision group had a 60% 
(South Africa), 53% (Kenya), and 51% (Uganda) 
lower incidence of HIV infection compared 
with men assigned to the wait-list group to be 
circumcised at the end of the study. In all three 
studies, a few men who had been assigned to 
be circumcised did not undergo the procedure, 
and vice versa. When the data were reanalyzed 
to account for these occurrences, men who had 
been circumcised had a 76% (South Africa), 60% 
(Kenya), and 55% (Uganda) reduction in risk for 
HIV infection compared with those who were not 
circumcised. The Uganda study investigators are 
also examining the following in an ongoing study: 
1) safety and acceptability of male circumcision 
in HIV-infected men and men of unknown HIV 
infection status, 2) safety and acceptability of male 
circumcision in the men’s female sex partners, and 
3) effect of male circumcision on male-to-female 
transmission of HIV and other STDs.
Male Circumcision and Male-to-Female 
Transmission of HIV
In an earlier study of couples in Uganda in which 
the male partner was HIV infected and the female 
partner was initially HIV-seronegative, the 
infection rates of the female partners differed by 
the circumcision status and viral load of the male 
partners. If the male’s HIV viral load was <50,000 
copies/mL, there was no HIV transmission if 
the man was circumcised, compared with a 
transmission rate of 9.6 per 100 person-years if 
the man was uncircumcised [7]. When viral load 
was not controlled for, there was a nonsignificant 
trend toward a reduction in the male-to-female 
transmission rate from circumcised men compared 
with uncircumcised men. Such an effect may be 
due to decreased viral shedding from circumcised 
men or to a reduction in ulcerative STDs acquired 
by female partners of circumcised men [12]. A 
clinical trial in Uganda to assess the impact of 
circumcision on male-to-female transmission 
reported that its first interim safety analysis 
showed a nonsignificant trend toward a higher rate 
of HIV acquisition in women partners of HIV-
seropositive men in couples who had resumed 
sex prior to certified postsurgical wound healing 
and did not detect a reduction in HIV acquisition 
by female partners engaging in sex after wound 
healing was complete [13].
Male Circumcision and Other 
Health Conditions
Lack of male circumcision has also been 
associated with sexually transmitted genital 
ulcer disease and chlamydia, infant urinary tract 
infections, penile cancer, and cervical cancer 
in female partners of uncircumcised men [1]. 
The latter two conditions are related to human 
papillomavirus (HPV) infection. Transmission 
of this virus is also associated with lack of male 
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circumcision. A recent meta-analysis included 
26 studies that assessed the association between 
male circumcision and risk for genital ulcer 
disease. The analysis concluded that there was a 
significantly lower risk for syphilis and chancroid 
among circumcised men, whereas the reduced 
risk of herpes simplex virus type 2 infection had a 
borderline statistical significance [4].
Risks Associated with Male 
Circumcision 
Reported complication rates depend on the type 
of study (e.g., chart review vs. prospective study), 
setting (medical vs. nonmedical facility), person 
operating (traditional vs. medical practitioner), 
patient age (infant vs. adult), and surgical 
technique or instrument used. In large studies of 
infant circumcision in the United States, reported 
inpatient complication rates range from 0.2% to 
2.0% [1, 14, 15]. The most common complications 
in the United States are minor bleeding and local 
infection. In the recently completed African trials 
of adult circumcision, the rates of adverse events 
possibly, probably, or definitely attributable to 
circumcision ranged from 2% to 8%. The most 
commonly reported complications were pain or 
mild bleeding. There were no reported deaths or 
long-term sequelae documented [9, 10, 11, 16]. 
A recent case-control study of two outbreaks 
of methicillin-resistant Staphylococcus aureus 
(MRSA) in otherwise healthy male infants at one 
hospital identified circumcision as a potential risk 
factor. However, in no case did MRSA infections 
involve the circumcision site, anesthesia injection 
site, or the penis, and MRSA was not found on any 
of the circumcision equipment or anesthesia vials 
tested [17]. 
Effects of Male Circumcision 
on Penile Sensation and Sexual 
Function
Well-designed studies of sexual sensation and 
function in relation to male circumcision are 
few, and the results present a mixed picture. 
Taken as a whole, the studies suggest that some 
decrease in sensitivity of the glans to fine touch 
can occur following circumcision [18]. However, 
several studies conducted among men after adult 
circumcision suggest that few men report their 
sexual functioning is worse after circumcision; 
most report either improvement or no change 
[19–22]. The three African trials found high levels 
of satisfaction among the men after circumcision 
[9, 10, 11, 16]; however, cultural differences limit 
extrapolation of their findings to U.S. men. 
HIV Infection and Male 
Circumcision in the United 
States
In 2005, men who have sex with men (MSM) 
(48%), MSM who also inject drugs (4%), and 
men (11%) and women (21%) exposed through 
high-risk heterosexual contact accounted for an 
estimated 84% of all HIV/AIDS cases diagnosed 
in U.S. areas with confidential name-based HIV 
infection reporting. Blacks accounted for 49% 
of cases and Hispanics for 18%. Infection rates 
for both groups were several-fold higher than 
the rate for whites. An overall prevalence of 
0.5% was estimated for the general population 
[23]. Although data on HIV infection rates since 
the beginning of the epidemic are available, 
data on circumcision and risk for HIV infection 
in the United States are limited. In one cross-
sectional survey of MSM, lack of circumcision 
was associated with a 2-fold increase in the 
odds of prevalent HIV infection [24]. In another, 
prospective study of MSM, lack of circumcision 
was also associated with a 2-fold increase in risk 
for HIV seroconversion [25]. In both studies, the 
results were statistically significant, and the data 
had been controlled statistically for other possible 
risk factors. However, in another prospective 
cohort study of MSM, there was no association 
between circumcision status and incident HIV 
infection, even among men who reported no 
unprotected anal receptive intercourse [26]. And in 
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a recent cross-sectional study of African American 
and Latino MSM, male circumcision was not 
associated with previously known or newly 
diagnosed HIV infection [27]. In one prospective 
study of heterosexual men attending an urban STD 
clinic, when other risk factors were controlled, 
uncircumcised men had a 3.5-fold higher risk for 
HIV infection than men who were circumcised. 
However, this association was not statistically 
significant [28]. And in an analysis of clinic 
records for African American men attending an 
STD clinic, circumcision was not associated with 
HIV status overall, but among men with known 
HIV exposure, circumcision was associated with 
a statistically significant 58% reduction in risk for 
HIV infection [29].
Status of Male Circumcision in the  
United States
In national probability samples of adults surveyed 
during 1999–2004, the National Health and 
Nutrition Examination Surveys (NHANES) found 
that 79% of men reported being circumcised, 
including 88% of non-Hispanic white men, 73% 
of non-Hispanic black men, 42% of Mexican 
American men, and 50% of men of other races/
ethnicities [30]. It is important to note that 
reported circumcision status may be subject to 
misclassification. In a study of adolescents¸ only 
69% of circumcised and 65% of uncircumcised 
young men correctly identified their circumcision 
status as verified by physical exam [31]. 
According to the National Hospital Discharge 
Survey (NHDS), 65% of newborns were 
circumcised in 1999, and the overall proportion 
of newborns circumcised was stable from 1979 
through 1999 [32]. Notably, the proportion of 
black newborns circumcised increased during this 
reporting period (58% to 64%); the proportion 
of white newborns circumcised remained stable 
(66%). In addition, the proportion of newborns 
who were circumcised in the Midwest increased 
during the 20-year period—from 74% in 1979 to 
81% in 1999; the proportion of infants born in 
the West who were circumcised decreased from 
64% in 1979 to 37% in 1999. In another survey, 
the National Inpatient Sample (NIS), circumcision 
rates increased from 48% during 1988–1991 to 
61% during 1997–2000. Circumcision was more 
common among newborns who were born to 
families of higher socioeconomic status, born in 
the Northeast or Midwest, and who were  
black [33]. 
In 1999, the American Academy of Pediatrics 
(AAP) changed from a neutral stance on 
circumcision to a position that the data then 
available were insufficient to recommend routine 
neonatal male circumcision. The Academy also 
stated, “It is legitimate for the parents to take into 
account cultural, religious, and ethnic traditions, 
in addition to medical factors, when making this 
choice” [34]. This position was reaffirmed by the 
Academy in 2005. This change in policy may have 
influenced reimbursement for, and the practice of, 
neonatal circumcision. In a 1995 review, 61% of 
circumcisions were paid for by private insurance, 
36% were paid for by Medicaid, and 3% were 
self-paid by the parents of the infant. Compared 
with infants of self-pay parents, those covered 
by private insurance were 2.5 times as likely to 
be circumcised [35]. Since 1999, 16 states have 
eliminated Medicaid payments for circumcisions 
that were not deemed medically necessary [36]. 
However, AAP has recently (2007) convened a 
panel to reconsider its circumcision policy in light 
of additional data now available.
Cost-Benefits and Ethical Issues for 
Neonatal Circumcision in the United States
A large retrospective study of circumcision in 
nearly 15,000 infants found neonatal circumcision 
to be highly cost-effective, considering the 
estimated number of averted cases of infant 
urinary tract infection and lifetime incidence of 
HIV infection, penile cancer, balanoposthitis, and 
phimosis. The cost of postneonatal circumcision 
was 10-fold the cost of neonatal circumcision [37].
Many parents now make decisions about infant 
circumcision based on cultural, religious, or 
parental desires rather than health concerns [38]. 
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Some persons have raised ethical objections to 
asking parents to make decisions about elective 
surgery during infancy, particularly when it is 
done primarily to protect against risks of HIV 
and STDs that don’t occur until young adulthood, 
but other ethicists have found it an appropriate 
parental proxy decision [39].
Considerations for the United States
A number of important differences from sub-
Saharan African settings where the three male 
circumcision trials were conducted must be 
considered in determining the possible role for 
male circumcision in HIV prevention in the United 
States. Notably, the overall risk of HIV infection is 
considerably lower in the United States, changing 
risk-benefit and cost-effectiveness considerations. 
Also, studies to date have demonstrated efficacy 
only for penile-vaginal sex, the predominant 
mode of HIV transmission in Africa, whereas the 
predominant mode of sexual HIV transmission 
in the United States is by penile-anal sex among 
MSM. There are as yet no convincing data to help 
determine whether male circumcision will have 
any effect on HIV risk for men who engage in anal 
sex with either a female or male partner, as either 
the insertive or receptive partner. Receptive anal 
sex is associated with a substantially greater risk 
of HIV acquisition than is insertive anal sex. It is 
more biologically plausible that male circumcision 
would reduce HIV acquisition risk for the insertive 
partner rather than for the receptive partner, but 
few MSM engage solely in insertive anal sex [40].
In addition, although the prevalence of 
circumcision may be somewhat lower in U.S. 
racial and ethnic groups with higher rates of 
HIV infection, most American men are already 
circumcised, and it is not known whether men at 
higher risk for HIV infection would be willing 
to be circumcised or whether parents would be 
willing to have their infants circumcised to reduce 
possible future HIV infection risk. Lastly, whether 
the effect of male circumcision differs by HIV-1 
subtype, predominately subtype B in the United 
States and subtypes A, C, and D in circulation 
at the three clinical trial sites in Africa, is also 
unknown.
Summary
Male circumcision has been associated with a 
lower risk for HIV infection in international 
observational studies and in three randomized 
controlled clinical trials. It is possible, but not 
yet adequately assessed, that male circumcision 
could reduce male-to-female transmission of 
HIV, although probably to a lesser extent than 
female-to-male transmission. Male circumcision 
has also been associated with a number of other 
health benefits. Although there are risks to male 
circumcision, serious complications are rare. 
Accordingly, male circumcision, together with 
other prevention interventions, could play an 
important role in HIV prevention in settings 
similar to those of the clinical trials [41, 42]. 
Male circumcision may also have a role in the 
prevention of HIV transmission in the United 
States. CDC consulted with external experts 
in April 2007 to receive input on the potential 
value, risks, and feasibility of circumcision as an 
HIV prevention intervention in the United States 
and to discuss considerations for the possible 
development of guidelines. 
As CDC proceeds with the development of public 
health recommendations for the United States, 
individual men may wish to consider circumcision 
as an additional HIV prevention measure, but they 
must recognize that circumcision 1) does carry 
risks and costs that must be considered in addition 
to potential benefits; 2) has only proven effective 
in reducing the risk of infection through insertive 
vaginal sex; and 3) confers only partial protection 
and should be considered only in conjunction with 
other proven prevention measures (abstinence, 
mutual monogamy, reduced number of sex 
partners, and correct and consistent condom use).
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